Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Assessment of Cognitive Function Before and After Conversion From Immediate Release Tacrolimus to Envarsus XR

Trial Profile

Assessment of Cognitive Function Before and After Conversion From Immediate Release Tacrolimus to Envarsus XR

Recruiting
Phase of Trial: Phase 0

Latest Information Update: 14 Nov 2018

At a glance

  • Drugs Tacrolimus (Primary)
  • Indications Renal transplant rejection
  • Focus Pharmacodynamics
  • Most Recent Events

    • 01 Nov 2018 Planned End Date changed from 1 Dec 2019 to 1 Feb 2020.
    • 01 Nov 2018 Planned primary completion date changed from 1 Aug 2019 to 1 Nov 2019.
    • 10 Jul 2018 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top